Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Silva

Showing results (101-110 of 150) with videos related to

Pageof 15
Sort By:
Plos One|May 17, 2019
Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shockToni Jäntti, Tuukka Tarvasmäki, Veli-Pekka Harjola, et al.
Biomaterials|December 23, 2011
Tethered spheroids as an in vitro hepatocyte model for drug safety screeningLei Xia, Rashidah Binte Sakban, Yinghua Qu, et al.
Journal of Cardiovascular Electrophysiology|April 3, 2024
Association between proactive esophageal cooling and increased lab throughputWilliam Zagrodzky, Julie Cooper, Christopher Joseph, et al.
International Journal of Biological Macromolecules|June 24, 2020
Comprehensive review on Caelsalpinioideae lectins: From purification to biological activitiesBenildo Sousa Cavada, Vanir Reis Pinto-Junior, Vinicius Jose Silva Osterne, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2018
Discovery of a novel potent GPR40 full agonistSanath K Meegalla, Hui Huang, Tonya Martin, et al.
European Journal of Heart Failure|March 31, 2015
Clinical picture and risk prediction of short-term mortality in cardiogenic shockVeli-Pekka Harjola, Johan Lassus, Alessandro Sionis, et al.
Annals of Intensive Care|February 6, 2021
Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shockToni Jäntti, Tuukka Tarvasmäki, Veli-Pekka Harjola, et al.
In Vivo (Athens, Greece)|April 27, 2023
Induction Therapy With Cisplatin, 5-Fluorouracil, Leucovorin, and Paclitaxel in Patients With Head and Neck CancerCarlos Eduardo Coelho DE Sa, Daniel DE Iracema Gomes Cubero, Rafael Everton Assuncao Ribeiro DA Costa, et al.
European Heart Journal. Acute Cardiovascular Care|August 11, 2022
Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shockMari Hongisto, Johan Lassus, Tuukka Tarvasmäki, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2017
Discovery of novel benzo[b]thiophene tetrazoles as non-carboxylate GPR40 agonistsHui Huang, Michael P Winters, Sanath K Meegalla, et al.
Pageof 15

Showing results (101-110 of 150) with videos related to

Sort By:
Pageof 15
Plos One|May 17, 2019
Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shockToni Jäntti, Tuukka Tarvasmäki, Veli-Pekka Harjola, et al.
Biomaterials|December 23, 2011
Tethered spheroids as an in vitro hepatocyte model for drug safety screeningLei Xia, Rashidah Binte Sakban, Yinghua Qu, et al.
Journal of Cardiovascular Electrophysiology|April 3, 2024
Association between proactive esophageal cooling and increased lab throughputWilliam Zagrodzky, Julie Cooper, Christopher Joseph, et al.
International Journal of Biological Macromolecules|June 24, 2020
Comprehensive review on Caelsalpinioideae lectins: From purification to biological activitiesBenildo Sousa Cavada, Vanir Reis Pinto-Junior, Vinicius Jose Silva Osterne, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2018
Discovery of a novel potent GPR40 full agonistSanath K Meegalla, Hui Huang, Tonya Martin, et al.
European Journal of Heart Failure|March 31, 2015
Clinical picture and risk prediction of short-term mortality in cardiogenic shockVeli-Pekka Harjola, Johan Lassus, Alessandro Sionis, et al.
Annals of Intensive Care|February 6, 2021
Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shockToni Jäntti, Tuukka Tarvasmäki, Veli-Pekka Harjola, et al.
In Vivo (Athens, Greece)|April 27, 2023
Induction Therapy With Cisplatin, 5-Fluorouracil, Leucovorin, and Paclitaxel in Patients With Head and Neck CancerCarlos Eduardo Coelho DE Sa, Daniel DE Iracema Gomes Cubero, Rafael Everton Assuncao Ribeiro DA Costa, et al.
European Heart Journal. Acute Cardiovascular Care|August 11, 2022
Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shockMari Hongisto, Johan Lassus, Tuukka Tarvasmäki, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2017
Discovery of novel benzo[b]thiophene tetrazoles as non-carboxylate GPR40 agonistsHui Huang, Michael P Winters, Sanath K Meegalla, et al.
Pageof 15